Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 4/20 | 0.54 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.54 |
| ▸ | TSHR | P16473 | 1/20 | 0.48 |
| ▸ | TERT | O14746 | 3/20 | 0.47 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.47 |
| ▸ | PPARG | P37231 | 3/20 | 0.47 |
| ▸ | PPARD | Q03181 | 3/20 | 0.47 |
| ▸ | PPARA | Q07869 | 3/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.47 |
| ▸ | MAPT | P10636 | 2/20 | 0.47 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.47 |
| ▸ | BLM | P54132 | 2/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.47 |
| ▸ | FABP4 | P15090 | 2/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.47 |
| ▸ | GMNN | O75496 | 1/20 | 0.47 |
| ▸ | USP2 | O75604 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL158907 | 1.00 | FAAH (0.54) | FAAHTRPV1TSHRTERTPTPN1 | |
| SCHEMBL2163660 | 1.00 | FAAH (0.54) | FAAHTRPV1TSHRTERTPTPN1 | |
| SCHEMBL2163401 | 1.00 | FAAH (0.54) | FAAHTRPV1TSHRTERTPTPN1 | |
| SCHEMBL16431159 | 1.00 | FAAH (0.54) | FAAHTRPV1TSHRTERTPTPN1 | |
| SCHEMBL910497 | 1.00 | FAAH (0.54) | FAAHTRPV1TSHRTERTPTPN1 | |
| SCHEMBL548514 | 1.00 | FAAH (0.54) | FAAHTRPV1TSHRTERTPTPN1 | |
| SCHEMBL548521 | 1.00 | FAAH (0.54) | FAAHTRPV1TSHRTERTPTPN1 | |
| SCHEMBL1240474 | 1.00 | FAAH (0.54) | FAAHTRPV1TSHRTERTPTPN1 | |
| SCHEMBL158906 | 1.00 | FAAH (0.54) | FAAHTRPV1TSHRTERTPTPN1 | |
| SCHEMBL9696115 | 1.00 | FAAH (0.54) | FAAHTRPV1TSHRTERTPTPN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 349 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107074762-B | Use of esters of N-acylated derivatives of amino acids and polyols as anti-ageing agents for human skin | 化工产品开发公司SEPPIC | 2021-06-15 | — | — | CN | claimed |
| EP-3212615-B1 | USE OF ESTERS OF N-ACYLATED DERIVATIVES OF AMINO ACIDS AND POLYOLS AS AN ANTI-AGEING AGENT FOR HUMAN SKIN | SOC DEXPLOITATION DE PRODUITS POUR LES INDUSTRIES CHIMIQUES SEPPIC (FR) | 2018-08-29 | — | — | EP | claimed |
| EP-2771318-B1 | NOVEL ESTERS OF N-ACYL DERIVATIVES OF AMINO ACIDS AND DIOLS, METHOD FOR PREPARING SAME, AND USE THEREOF IN COSMETICS AND AS A DRUG | SOC DEXPLOITATION DE PRODUITS POUR LES INDUSTRIES CHIMIQUES SEPPIC (FR) | 2018-06-06 | — | — | EP | claimed |
| US-20170312205-A1 | USE OF ESTERS OF N-ACYLATED DERIVATIVES OF AMINO ACIDS AND POLYOLS AS AN ANTI-AGEING AGENT FOR HUMAN SKIN | SOCIETE D'EXPLOITATION DE PRODUITS POUR LES INDUSTRIES CHIMIQUES SEPPIC (FR) | 2017-11-02 | — | — | US | claimed |
| US-9567290-B2 | Esters of N-acyl derivatives of amino acids and diols, method for preparing same, and use thereof in cosmetics and as a drug | SOCIETE D'EXPLOITATION DE PRODUITS POUR LES INDUSTRIES CHIMIQUES SEPPIC (FR) | 2017-02-14 | — | — | US | claimed |
| US-8906409-B2 | Acoustically sensitive drug delivery particles comprising non-lamellar forming phosphatidylcholine | EPITARGET AS (DE) | 2014-12-09 | — | — | US | claimed |
| US-20140288144-A1 | NOVEL ESTERS OF N-ACYL DERIVATIVES OF AMINO ACIDS AND DIOLS, METHOD FOR PREPARING SAME, AND USE THEREOF IN COSMETICS AND AS A DRUG | SOCIETE D'EXPLOITATION DE PRODUITS POUR LES INDUSTRIES CHIMIQUES SEPPIC (FR) | 2014-09-25 | — | — | US | claimed |
| US-8765172-B2 | Acoustically sensitive drug delivery particles comprising non-lamellar forming lipids | EPITARGET AS (NO) | 2014-07-01 | — | — | US | claimed |
| US-20130017248-A1 | Cationic Liposomes And Method of Use | Life Technologies Corporation (US) | 2013-01-17 | — | — | US | claimed |
| US-20120189689-A1 | ACOUSTICALLY SENSITIVE DRUG DELIVERY PARTICLES COMPRISING NON-LAMELLAR FORMING PHOSPHATIDYLCHOLINE | EPITARGET AS (NO) | 2012-07-26 | — | — | US | claimed |
| WO-2001042405-A2 | WATER SOLUBLE VEGETABLE OIL ESTERS FOR INDUSTRIAL APPLICATIONS | CARGILL INCORPORATED (US) | 2001-06-14 | — | — | WO | claimed |
| US-20010002257-A1 | Composition comprising a lipoamino acid and the constituents of a tannin-rich plant extract, and cosmetic use thereof | STOLZ CORINNE (FR) | 2001-05-31 | — | — | US | claimed |
| EP-0986570-A1 | GEMCITABINE DERIVATIVES | NORSK HYDRO ASA (NO) | 2000-03-22 | — | — | EP | claimed |
| WO-1998032762-A1 | GEMCITABINE DERIVATIVES | NORSK HYDRO ASA (NO) | 1998-07-30 | — | — | WO | claimed |
| EP-0842185-A1 | IMPROVED THERAPEUTIC AGENTS | NORSK HYDRO a.s. (NO) | 1998-05-20 | — | — | EP | claimed |
| WO-1997005154-A1 | IMPROVED THERAPEUTIC AGENTS | NORSK HYDRO ASA (NO) | 1997-02-13 | — | — | WO | claimed |
| EP-0349579-B1 | LIPID VESICLES FORMED OF SURFACTANTS AND STEROIDS | MICRO VESICULAR SYSTEMS, INC. (US) | 1992-01-08 | — | — | EP | claimed |
| US-4917951-A | POLYOXYETHYLENE ETHERS OR AMINES | MICRO-PAK, INC. (US) | 1990-04-17 | — | — | US | claimed |
| EP-0349579-A1 | LIPID VESICLES FORMED OF SURFACTANTS AND STEROIDS. | MICRO VESICULAR SYSTEMS (US) | 1990-01-10 | — | — | EP | claimed |
| WO-1988006882-A1 | LIPID VESICLES FORMED OF SURFACTANTS AND STEROIDS | MICRO VESICULAR SYSTEMS, INC. (US) | 1988-09-22 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170312205-A1 | USE OF ESTERS OF N-ACYLATED DERIVATIVES OF AMINO ACIDS AND POLYOLS AS AN ANTI-AGEING AGENT FOR HUMAN SKIN | LPO, ARG2, CUTA | FAAH 304/4885TRPV1 2280/4885TSHR 4158/4885 |
| US-20010002257-A1 | Composition comprising a lipoamino acid and the constituents of a tannin-rich plant extract, and cosmetic use thereof | LIPC, PLIN1, LRAT | FAAH 33/4885TRPV1 1068/4885TSHR 2099/4885 |
| US-20140288144-A1 | NOVEL ESTERS OF N-ACYL DERIVATIVES OF AMINO ACIDS AND DIOLS, METHOD FOR PREPARING SAME, AND USE THEREOF IN COSMETICS AND AS A DRUG | DAO, ACOX3, IL4I1 | FAAH 695/4885TRPV1 2495/4885TSHR 1787/4885 |
| US-20130017248-A1 | Cationic Liposomes And Method of Use | CLTB, AGBL2, CLTC | FAAH 3441/4885TRPV1 3914/4885TSHR 3348/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.